BAY 94-8862, Finerenone, Placebo coated tablet 002 to BAY 948862 coated tablet
P01351
Phase 3 small_molecule active
Quick answer
BAY 94-8862, Finerenone, Placebo coated tablet 002 to BAY 948862 coated tablet for Chronic kidney disease is a Phase 3 program (small_molecule) at Institut für biomedizinische Analytik NMR-Imaging GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Institut für biomedizinische Analytik NMR-Imaging GmbH
- Indication
- Chronic kidney disease
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active